Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1575-1583

  Bergmann, C C ^a   Ramakrishna, C ^a   Kornacki, M ^a   Stohlman, S A ^a  

^a MCH 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FLOW CYTOMETRY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MONONUCLEAR CELL; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0035424120     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1575     Document Type: Article

References (57)

1. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
2. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes
3. Viral immune evasion due to persistence of activated cells without effector function
4. + T cells upon acute versus persistent viral infection
5. Differential cytotoxic T-lymphocyte responsiveness to hepatitis B and C viruses in chronically infected patients
6. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease
7. Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice
8. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
9. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
10. CD8 Tcell memory in B cell-deficient mice
11. + T cell memory in the absence of B cells and Ig
12. + T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells
13. Immunity to viruses in B cell-deficient mice: Influence of antibodies on virus persistence and on T cell memory
14. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
15. Mechanism of protective immunity against influenza virus infection in mice without antibodies
16. Evidence of an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from μMT/μMT mice
17. Antibody prevents virus reactivation within the central nervous system
18. B cell deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality
19. Role of antibodies in controlling viral disease: Lessons from experiments of nature and gene knockouts
20. The role of antibody in recovery from alphavirus encephalitis
21. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from oligodendroglia
22. + T cells
23. IFN-γ is required for viral clearance from central nervous system oligodendroglia
24. + T cells during viral persistence in the CNS
25. Mouse hepatitis virus
26. Murine coronavirus infection: A paradigm for virus-induced demyelinating disease
27. Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA
28. Variability of persisting MHV RNA sequences comprising immune and replication relevant domains
29. Mouse hepatitis virus is cleared from the central nervous system of mice lacking perforin-mediated cytolysis
30. Pathogenicity of antigenic variants of murine coronavirus JHM selected with mAb
31. Murine coronaviruses: Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain
32. + T cells
33. + cells with highly focused specificity during viral persistence in the central nervous system
34. + T cells within the CNS
35. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain
36. d-restricted cytotoxic T lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein
37. b-restricted cytotoxic T cell response
38. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity
39. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus
40. Immunological memory and protective immunity: Understanding their relation
41. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans
42. Dissection of an inflammatory process induced by CD8 T cells
43. Natural antibodies and complement link innate and acquired immunity
44. The role of CD4 and CD8 T cells in viral infection
45. + cytotoxic T cell responses during chronic viral infection
46. + T helper cells in the cytotoxic T lymphocyte response to HIV-1
47. Effector CD4 and CD8 T cell mechanisms in the control of respiratory infections
48. Trafficking of adoptively transferred B lymphocytes in B-lymphocyte-deficient mice
49. Cervical lymphatics, the blood brain barrier, and the immunoreactivity of the brain
50. Antigen presentation in the central nervous system
51. Fas-Fas ligand interactions do not contribute to the pathogenesis of mouse hepatitis virus in the central nervous system
52. Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice
53. A critical role of B cells in the development of memory CD4 cells
54. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses
55. Virus dissemination through the brain parenchyma without immunologic control
56. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: Evidence for a Th-independent contribution by B cells to virus clearance
57. B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type I deviation